조영 증강 초음파 시장의 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Contrast Enhanced Ultrasound Market Growth & Trends:

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030 and grow at a CAGR of 5.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer, cardiovascular, and liver disorders drives the demand for accurate and early diagnosis. Patients and clinicians increasingly favor noninvasive procedures like Contrast Enhanced Ultrasound (CEUS) due to their safety, speed, and lack of radiation exposure. This growing preference and the need for ongoing disease monitoring fuel rapid adoption of CEUS technologies across global healthcare systems, thereby expanding market size and clinical utilization.

Global investments in healthcare infrastructure fuel the adoption of advanced diagnostic tools like CEUS. Modern hospitals and diagnostic centers are increasingly equipping themselves with CEUS systems to improve patient care. In addition, an aging population contributes to a surge in chronic conditions that require regular imaging. These demographic and infrastructure trends are significantly increasing the demand for CEUS, making it a vital component of modern diagnostic strategies worldwide.

Ongoing innovations in ultrasound technology and contrast agent development enhance the accuracy, efficiency, and safety of CEUS. These improvements have broadened CEUS applications across multiple medical fields, including oncology, cardiology, and nephrology. The ability to use CEUS for real-time, detailed imaging in various organs supports faster, more informed clinical decisions. This expansion into diverse diagnostic areas is expected to drive widespread adoption and boost market growth over the coming years.

Contrast Enhanced Ultrasound Market Report Highlights:

• By product, the equipment segment held the largest share of 71.7% in 2024 due to the rising adoption of advanced ultrasound systems and increasing demand for precise diagnostic tools.
• The contrast agents segment is anticipated to be the fastest-growing segment from 2025 to 2030,fueled bythe rising prevalence of chronic diseases and growing awareness of noninvasive diagnostic procedures.
• By type, the non-targeted segment led the market with the largest revenue share in 2024, attributed to its broad clinical applicability and ease of use.
• By end use, the hospitals segment dominated the market with the largest share in 2024, owing to high patient volumes, access to advanced imaging technologies, and the availability of skilled professionals.
• North America accounted for the largest revenue share of 34.6% in 2024, propelled bya well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and favorable reimbursement policies for CEUS procedures.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Type Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional Outlook
• 2.3. Competitive Scenario

Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Contrast Enhanced Ultrasound Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Contrast Enhanced Ultrasound Market: Product Movement Analysis
• 4.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
• 4.4. Equipment
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Contrast Agents
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis

• 5.1. Type Segment Dashboard
• 5.2. Contrast Enhanced Ultrasound Market: Type Movement Analysis
• 5.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
• 5.4. Non-targeted
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Targeted
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Contrast Enhanced Ultrasound Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Contrast Enhanced Ultrasound Market: End Use Movement Analysis
• 6.3. Global Contrast Enhanced Ultrasound Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Clinics
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Ambulatory Diagnostic Centers
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Contrast Enhanced Ultrasound Market by Region: Key Takeaways
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key Country Dynamics
    • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.1.3. Competitive Scenario
    • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. U.K.
    • 7.5.1.1. Key Country Dynamics
    • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.1.3. Competitive Scenario
    • 7.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key Country Dynamics
    • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.1.3. Competitive Scenario
    • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.8. Middle East and Africa
  • 7.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.3.3. Competitive Scenario
    • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.4.3. Competitive Scenario
    • 7.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 7.8.5.3. Competitive Scenario
    • 7.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/ Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key Company Heat Map Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. Lantheus
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. GE HealthCare
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Bracco
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Siemens Healthineers AG
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Koninklijke Philips N.V.
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. CANON MEDICAL SYSTEMS CORPORATION
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives